Management of monoclonal gammopathy of renal significance: treatment standard
Nephrology Dialysis Transplantation · 2026
DOI: 10.1093/ndt/gfaf254 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Solos Jaturapisanukul und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Renal Replacement Therapy Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University,…. Hauptthemen laut MEDLINE: Paraproteinemias, Kidney Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Multiple Myeloma.
Abstract (Originalsprache)
Monoclonal gammopathy of renal significance (MGRS) is a heterogeneous group of clonal B cell or plasma cell proliferative disorders that cause kidney injury without meeting criteria for overt malignancy. Advances in diagnostic techniques have enhanced the identification and classification of MGRS lesions. Clone-directed therapies such as proteasome inhibitors, anti-CD38 and anti-CD20 monoclonal antibodies are now central to treatment, targeting a deep haematologic response that is strongly associated with improved renal outcomes and reduced risk of recurrence following kidney transplantation. Despite these advances, management remains challenging in patients without detectable clones. This review highlights recent progress in the diagnosis and treatment of MGRS, with an emphasis on therapeutic strategies, transplant considerations and evolving clinical challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology and Renal Replacement Therapy Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
- Divisions of Nephrology and Hypertension and Hematology, Mayo Clinic, Rochester, MN, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Nelson Leung
Förderung
- Multiple Myeloma
Zitieren
APA
Jaturapisanukul, S., Nasr, S. H., & Leung, N. (2026). Management of monoclonal gammopathy of renal significance: treatment standard. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf254
Vancouver
Jaturapisanukul S, Nasr SH, Leung N. Management of monoclonal gammopathy of renal significance: treatment standard. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf254
BibTeX
@article{Jaturapisanukul2026,
author = {Jaturapisanukul, Solos and Nasr, Samih H and Leung, Nelson},
title = {Management of monoclonal gammopathy of renal significance: treatment standard},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
doi = {10.1093/ndt/gfaf254}
}
EUVIMED